As the TGF-β1 pathway is well-known for its anti-inflammatory activity, a higher epithelial expression of TGF-β1 in patients with smoking-related emphysema compared with AAT-deficiency may partially justify the different patterns of inflammation in the two types of emphysema, as found in our study. Here, TGFB1 is linked to pulmonary emphysema.